The rise of Big Data along with shrinking research funds mean it's time for a new model of partnership and collaboration in the medical science arena, writes Michael J. Fox Foundation CEO Todd Sherer. Open-source models such as the Alzheimer's Disease Neuroimaging Initiative and the Parkinson's Progression Marker's Initiative crowdsource analysis of data troves and "maximize the number of minds working on the problem in order to hasten the pace of investigation and drug development," Sherer writes. The National Center for Advancing Translational Sciences takes crowdsourcing a step further with its "Discovering New Therapeutic Uses for Existing Molecules," and cross-disciplinary collaborations that find overlapping pathologies in different diseases maximize impacts for more patients, he writes.
Published in Brief: